S&P 500   4,121.68 (-0.44%)
DOW   32,804.02 (-0.09%)
QQQ   316.26 (-1.39%)
AAPL   164.09 (-0.47%)
MSFT   279.03 (-0.46%)
META   167.47 (-1.63%)
GOOGL   116.01 (-1.10%)
AMZN   136.45 (-2.12%)
TSLA   851.90 (-2.22%)
NVDA   171.04 (-3.87%)
NIO   19.43 (-3.67%)
BABA   91.44 (+0.66%)
AMD   96.30 (-3.77%)
MU   58.50 (-4.80%)
T   18.21 (+1.17%)
CGC   3.01 (-8.23%)
GE   75.63 (+0.60%)
F   15.51 (-1.71%)
DIS   107.44 (-1.53%)
AMC   22.88 (-4.51%)
PYPL   94.35 (-1.98%)
PFE   49.93 (+0.73%)
NFLX   226.45 (-3.02%)
S&P 500   4,121.68 (-0.44%)
DOW   32,804.02 (-0.09%)
QQQ   316.26 (-1.39%)
AAPL   164.09 (-0.47%)
MSFT   279.03 (-0.46%)
META   167.47 (-1.63%)
GOOGL   116.01 (-1.10%)
AMZN   136.45 (-2.12%)
TSLA   851.90 (-2.22%)
NVDA   171.04 (-3.87%)
NIO   19.43 (-3.67%)
BABA   91.44 (+0.66%)
AMD   96.30 (-3.77%)
MU   58.50 (-4.80%)
T   18.21 (+1.17%)
CGC   3.01 (-8.23%)
GE   75.63 (+0.60%)
F   15.51 (-1.71%)
DIS   107.44 (-1.53%)
AMC   22.88 (-4.51%)
PYPL   94.35 (-1.98%)
PFE   49.93 (+0.73%)
NFLX   226.45 (-3.02%)
S&P 500   4,121.68 (-0.44%)
DOW   32,804.02 (-0.09%)
QQQ   316.26 (-1.39%)
AAPL   164.09 (-0.47%)
MSFT   279.03 (-0.46%)
META   167.47 (-1.63%)
GOOGL   116.01 (-1.10%)
AMZN   136.45 (-2.12%)
TSLA   851.90 (-2.22%)
NVDA   171.04 (-3.87%)
NIO   19.43 (-3.67%)
BABA   91.44 (+0.66%)
AMD   96.30 (-3.77%)
MU   58.50 (-4.80%)
T   18.21 (+1.17%)
CGC   3.01 (-8.23%)
GE   75.63 (+0.60%)
F   15.51 (-1.71%)
DIS   107.44 (-1.53%)
AMC   22.88 (-4.51%)
PYPL   94.35 (-1.98%)
PFE   49.93 (+0.73%)
NFLX   226.45 (-3.02%)
S&P 500   4,121.68 (-0.44%)
DOW   32,804.02 (-0.09%)
QQQ   316.26 (-1.39%)
AAPL   164.09 (-0.47%)
MSFT   279.03 (-0.46%)
META   167.47 (-1.63%)
GOOGL   116.01 (-1.10%)
AMZN   136.45 (-2.12%)
TSLA   851.90 (-2.22%)
NVDA   171.04 (-3.87%)
NIO   19.43 (-3.67%)
BABA   91.44 (+0.66%)
AMD   96.30 (-3.77%)
MU   58.50 (-4.80%)
T   18.21 (+1.17%)
CGC   3.01 (-8.23%)
GE   75.63 (+0.60%)
F   15.51 (-1.71%)
DIS   107.44 (-1.53%)
AMC   22.88 (-4.51%)
PYPL   94.35 (-1.98%)
PFE   49.93 (+0.73%)
NFLX   226.45 (-3.02%)
NYSE:ACB

Aurora Cannabis - ACB Stock Forecast, Price & News

$1.55
-0.10 (-6.06%)
(As of 08/9/2022 10:11 AM ET)
Add
Compare
Today's Range
$1.54
$1.68
50-Day Range
$1.23
$1.66
52-Week Range
$1.21
$8.69
Volume
126,738 shs
Average Volume
9.27 million shs
Market Capitalization
$351.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.10

Aurora Cannabis MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
228.8% Upside
$5.10 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.25mentions of Aurora Cannabis in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.65) to ($0.37) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.73 out of 5 stars

Medical Sector

928th out of 1,098 stocks

Medicinals & Botanicals Industry

10th out of 13 stocks

ACB stock logo

About Aurora Cannabis (NYSE:ACB) Stock

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aurora Cannabis Trading Up 10.0 %

Shares of ACB traded up $0.15 during mid-day trading on Monday, reaching $1.65. The company's stock had a trading volume of 14,512,984 shares, compared to its average volume of 8,743,105. The stock has a market cap of $374.22 million, a PE ratio of -0.36 and a beta of 2.74. The company has a current ratio of 5.85, a quick ratio of 4.76 and a debt-to-equity ratio of 0.32. Aurora Cannabis has a 52 week low of $1.21 and a 52 week high of $8.69. The company's fifty day moving average price is $1.43 and its two-hundred day moving average price is $2.80.

Aurora Cannabis (NYSE:ACB - Get Rating) last announced its quarterly earnings data on Thursday, May 12th. The company reported ($1.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.88). The business had revenue of $39.82 million during the quarter, compared to the consensus estimate of $40.58 million. Aurora Cannabis had a negative return on equity of 25.80% and a negative net margin of 542.50%. On average, analysts predict that Aurora Cannabis will post -1.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on ACB shares. CIBC cut their price target on shares of Aurora Cannabis from C$6.50 to C$3.75 in a research note on Monday, May 16th. Stifel Nicolaus raised shares of Aurora Cannabis from a "sell" rating to a "hold" rating and set a $2.15 price target for the company in a research note on Monday, June 6th. Finally, Cantor Fitzgerald raised shares of Aurora Cannabis from a "neutral" rating to an "overweight" rating in a research note on Friday, June 24th. Two analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $5.23.

Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

ACB Stock News Headlines

There Are Different Types of Stock To Invest In (ACB)
Stocks are divided into categories for specific reasons that may have a bearing on your investments Companies are most commonly divided by market capitalization
Is There Finally Green Ahead for These 2 Cannabis Leaders? (ACB)
With so many businesses going all-in on cannabis and stock price performance fledgling, many investors have been left scratching their heads. Let’s look at two of the most prominent cannabis stocks to see if the sea of red will ever shift to green.
Copper Exploration Heating Up
Canada is already known as a miner's paradise. But British Columbia (BC) is quietly becoming the new copper hotspot. That's because copper is critical to the world's shift to renewable energy. Biden earmarked $226 billion in new infrastructure projects all requiring copper.
Aurora Cannabis Inc stock advanced on Friday.
Better Buy: Sundial Growers vs. Aurora Cannabis
Copper Exploration Heating Up
Canada is already known as a miner's paradise. But British Columbia (BC) is quietly becoming the new copper hotspot. That's because copper is critical to the world's shift to renewable energy. Biden earmarked $226 billion in new infrastructure projects all requiring copper.
Aurora Cannabis Inc stock decreased on Friday.
Aurora Cannabis Inc - Stock Valuation ACB
Read Why Did Cantor Upgrade Aurora Cannabis Stock
Why Aurora Cannabis Stock Spiked Today
Aurora Cannabis Follows Tesla in Buzz-Killing Trend
Here's 1 Stock I'd Avoid at All Costs
Stocks in play: Aurora Cannabis Inc
IIROC Trade Resumption - ACB.WS.U
Aurora Cannabis upsizes bought deal financing
See More Headlines
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

ACB Company Calendar

Last Earnings
5/12/2022
Today
8/09/2022
Next Earnings (Estimated)
9/26/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
1,761
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.10
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$2.15
Forecasted Upside/Downside
+228.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

Net Income
$-542,590,000.00
Net Margins
-542.50%
Pretax Margin
-545.11%

Debt

Sales & Book Value

Annual Sales
$191.43 million
Book Value
$8.03 per share

Miscellaneous

Free Float
N/A
Market Cap
$351.54 million
Optionable
Optionable
Beta
2.74

Key Executives

  • Mr. Miguel Martin (Age 50)
    CEO & Director
    Comp: $1.66M
  • Mr. Glen Ibbott
    Chief Financial Officer
  • Mr. Carey Squires
    Exec. VP of Corp. Devel. & Strategy
  • Mr. Andre Jerome
    Exec. VP of Global Bus. Devel.
  • Mr. Alex Miller
    Exec. VP of Operations & Supply Chain
  • Dave Aird
    Exec. VP of Information Services
  • Ananth Krishnan
    VP of Capital Markets & Investor Relations
  • Nathalie Clark
    Exec. VP, Gen. Counsel & Corp. Sec.
  • Michelle Lefler
    VP of Communications & PR
  • Ms. Lori Schick
    Exec. VP of HR













ACB Stock - Frequently Asked Questions

Should I buy or sell Aurora Cannabis stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ACB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View ACB analyst ratings
or view top-rated stocks.

What is Aurora Cannabis' stock price forecast for 2022?

7 equities research analysts have issued twelve-month price objectives for Aurora Cannabis' shares. Their ACB share price forecasts range from $2.15 to $7.00. On average, they anticipate the company's stock price to reach $5.10 in the next twelve months. This suggests a possible upside of 208.9% from the stock's current price.
View analysts price targets for ACB
or view top-rated stocks among Wall Street analysts.

How has Aurora Cannabis' stock price performed in 2022?

Aurora Cannabis' stock was trading at $5.41 at the beginning of the year. Since then, ACB stock has decreased by 69.5% and is now trading at $1.65.
View the best growth stocks for 2022 here
.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, September 26th 2022.
View our ACB earnings forecast
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) issued its quarterly earnings data on Thursday, May, 12th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.88. The firm had revenue of $39.82 million for the quarter, compared to the consensus estimate of $40.58 million. Aurora Cannabis had a negative net margin of 542.50% and a negative trailing twelve-month return on equity of 25.80%.

When did Aurora Cannabis' stock split?

Aurora Cannabis shares reverse split before market open on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Cronos Group (CRON), NVIDIA (NVDA), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (0.79%), TD Asset Management Inc. (0.31%), Merlin Capital LLC (0.23%), Simplex Trading LLC (0.00%), Capital Wealth Alliance LLC (0.07%) and Commonwealth Equity Services LLC (0.06%).

How do I buy shares of Aurora Cannabis?

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $1.65.

How much money does Aurora Cannabis make?

Aurora Cannabis (NYSE:ACB) has a market capitalization of $374.22 million and generates $191.43 million in revenue each year. The company earns $-542,590,000.00 in net income (profit) each year or ($4.63) on an earnings per share basis.

How many employees does Aurora Cannabis have?

Aurora Cannabis employs 1,761 workers across the globe.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The official website for the company is auroramj.com. The company can be reached via phone at (855) 279-4652 or via email at ir@auroramj.com.

This page (NYSE:ACB) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.